[HTML][HTML] Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …
Research progress on the therapeutic effects of nanoparticles loaded with drugs against atherosclerosis
T Shi, K Liu, Y Peng, W Dai, D Du, X Li, T Liu… - … Drugs and Therapy, 2024 - Springer
Presently, there are many drugs for the treatment of atherosclerosis (AS), among which lipid-
lowering, anti-inflammatory, and antiproliferative drugs have been the most studied. These …
lowering, anti-inflammatory, and antiproliferative drugs have been the most studied. These …
Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications
A Zinger - Journal of Controlled Release, 2023 - Elsevier
In this contribution to the Orations-New Horizons of the Journal of Controlled Release, I
present design strategies for the two main biomimetic nanoparticles (BNP) groups: BNP …
present design strategies for the two main biomimetic nanoparticles (BNP) groups: BNP …
[HTML][HTML] Lipid conjugate dissociation analysis improves the in vivo understanding of lipid-based nanomedicine
Lipid conjugates have advanced the field of lipid-based nanomedicine by promoting active-
targeting (ligand, peptide, antibody), stability (PEGylation), controlled release (lipoid …
targeting (ligand, peptide, antibody), stability (PEGylation), controlled release (lipoid …
[HTML][HTML] Chiroptical detection and mutation analysis of cancer-associated extracellular vesicles using microfluidics with oriented chiral nanoparticles
Cancer-cell-secreted small extracellular vesicles, known as exosomes, represent a rapidly
emerging family of cancer biomarkers. However, the current protocols for exosome analysis …
emerging family of cancer biomarkers. However, the current protocols for exosome analysis …
Innovation of Lipid‐Based Nanoparticles: the Design and Applications in the Cardiovascular Disease Management
Z Gu, T Liu, W Rao, D Li, Q Zhang, J Dai… - Advanced Functional …, 2025 - Wiley Online Library
Cardiovascular diseases (CVDs) represent a prominent cause of global mortality, posing
considerable challenges for traditional therapies due to their limited bioavailability and …
considerable challenges for traditional therapies due to their limited bioavailability and …
Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy
Y Li, Q Feng, L Wang, X Gao, Y **, L Ye, J Ji… - Journal of Drug …, 2024 - Taylor & Francis
Atherosclerosis is one of the major causes of death worldwide, and it is closely related to
many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although …
many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although …
[PDF][PDF] Costus-loaded silver nanoparticles mitigated AMPK and related pathways in the albino rat atherosclerosis model
In the present study, the role of silver nanoparticles (AgNP)-loaded S. costus was
investigated in an atherosclerosis Albino rat model by testing AMP-activated protein kinase …
investigated in an atherosclerosis Albino rat model by testing AMP-activated protein kinase …
[PDF][PDF] an.(2024, No ember 19)
WL Os - from https://hdl. handle. net/1887/4139161 … - scholarlypublications …
Ad ancing image-based localization of lipid-based nanomedicines for the exploration of targeted
drug deli er Page 1 Ad ancing image-based localization of lipid-based nanomedicines for the …
drug deli er Page 1 Ad ancing image-based localization of lipid-based nanomedicines for the …